Detalhe da pesquisa
1.
Early clinical markers of aggressive multiple sclerosis.
Brain
; 143(5): 1400-1413, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32386427
2.
Risk of secondary progressive multiple sclerosis: A longitudinal study.
Mult Scler
; 26(1): 79-90, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31397221
3.
Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis.
Mult Scler
; 24(5): 642-652, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28382837
4.
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
Brain
; 140(9): 2426-2443, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29050389
5.
Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
Ann Neurol
; 80(1): 89-100, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27145331
6.
Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 88(3): 196-203, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27683916
7.
Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.
Mult Scler
; 23(10): 1346-1357, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27885062
8.
Contribution of different relapse phenotypes to disability in multiple sclerosis.
Mult Scler
; 23(2): 266-276, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27055805
9.
Defining secondary progressive multiple sclerosis.
Brain
; 139(Pt 9): 2395-405, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27401521
10.
Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis.
Ann Neurol
; 77(3): 425-35, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25546031
11.
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 87(12): 1343-1349, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27810919
12.
The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.
Mult Scler
; 22(4): 520-32, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26199347
13.
Defining reliable disability outcomes in multiple sclerosis.
Brain
; 138(Pt 11): 3287-98, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26359291
14.
Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.
Ann Neurol
; 76(6): 880-90, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25283272
15.
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.
Mult Scler
; 21(9): 1159-71, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25480857
16.
Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
Mult Scler
; 20(6): 739-46, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24107309
17.
Risk of relapse phenotype recurrence in multiple sclerosis.
Mult Scler
; 20(11): 1511-22, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24777276
18.
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
Brain
; 136(Pt 12): 3609-17, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24142147
19.
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry.
J Neurol Neurosurg Psychiatry
; 83(3): 305-10, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22205675
20.
Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study.
Mult Scler Relat Disord
; 28: 235-243, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30623864